Filing Details
- Accession Number:
- 0001209191-15-063116
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-07-31 16:49:44
- Reporting Period:
- 2013-11-01
- Filing Date:
- 2015-07-31
- Accepted Time:
- 2015-07-31 16:49:44
- Original Submission Date:
- 2013-11-05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1006028 | Pure Bioscience Inc. | PURE | Miscellaneous Chemical Products (2890) | 330530289 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1587257 | R. Henry Lambert | 1725 Gillespie Way El Cajon CA 92020 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-01 | 42,857 | $0.70 | 542,857 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The original Form 4 Report filed on November 5, 2013 stated the number of shares acquired as 40,000 at a price of $0.75 per share.